A fully implantable pacemaker for the mouse: From battery to wireless power by Laughner, Jacob I et al.




A fully implantable pacemaker for the mouse: From
battery to wireless power
Jacob I. Laughner
Washington University in St Louis
Scott B. Marrus
Washington University School of Medicine in St. Louis
Erik R. Zellmer
Washington University in St Louis
Carla J. Weinheimer
Washington University School of Medicine in St. Louis
Matthew R. MacEwan
Washington University in St Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Laughner, Jacob I.; Marrus, Scott B.; Zellmer, Erik R.; Weinheimer, Carla J.; MacEwan, Matthew R.; Cui, Sophia X.; Nerbonne, Jeanne




Jacob I. Laughner, Scott B. Marrus, Erik R. Zellmer, Carla J. Weinheimer, Matthew R. MacEwan, Sophia X.
Cui, Jeanne M. Nerbonne, and Igor R. Efimov
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/1952
A Fully Implantable Pacemaker for the Mouse: From
Battery to Wireless Power
Jacob I. Laughner1., Scott B. Marrus2., Erik R. Zellmer1, Carla J. Weinheimer2, Matthew R. MacEwan1,
Sophia X. Cui1, Jeanne M. Nerbonne3, Igor R. Efimov1*
1Department of Biomedical Engineering, Washington University in Saint Louis, Saint Louis, Missouri, United States of America, 2Department of Internal Medicine, Division
of Cardiovascular Sciences, Washington University in Saint Louis, Saint Louis, Missouri, United States of America, 3Department of Developmental Biology, Washington
University in Saint Louis, Saint Louis, Missouri, United States of America
Abstract
Animal models have become a popular platform for the investigation of the molecular and systemic mechanisms of
pathological cardiovascular physiology. Chronic pacing studies with implantable pacemakers in large animals have led to
useful models of heart failure and atrial fibrillation. Unfortunately, molecular and genetic studies in these large animal
models are often prohibitively expensive or not available. Conversely, the mouse is an excellent species for studying
molecular mechanisms of cardiovascular disease through genetic engineering. However, the large size of available
pacemakers does not lend itself to chronic pacing in mice. Here, we present the design for a novel, fully implantable
wireless-powered pacemaker for mice capable of long-term (.30 days) pacing. This design is compared to a traditional
battery-powered pacemaker to demonstrate critical advantages achieved through wireless inductive power transfer and
control. Battery-powered and wireless-powered pacemakers were fabricated from standard electronic components in our
laboratory. Mice (n = 24) were implanted with endocardial, battery-powered devices (n = 14) and epicardial, wireless-
powered devices (n = 10). Wireless-powered devices were associated with reduced implant mortality and more reliable
device function compared to battery-powered devices. Eight of 14 (57.1%) mice implanted with battery-powered
pacemakers died following device implantation compared to 1 of 10 (10%) mice implanted with wireless-powered
pacemakers. Moreover, device function was achieved for 30 days with the wireless-powered device compared to 6 days
with the battery-powered device. The wireless-powered pacemaker system presented herein will allow electrophysiology
studies in numerous genetically engineered mouse models as well as rapid pacing-induced heart failure and atrial
arrhythmia in mice.
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Introduction
The use of animal models of human disease processes plays an
essential role in bio-medical research. Models of cardiovascular
disease offer unique challenges since these diseases are multifac-
torial, often with contributing environmental causes that take years
to fully manifest. One versatile maneuver is altering heart rate with
the implantation of a cardiac pacemaker, a small electronic device
connected to the heart with wires or leads. In animal models, the
induction of rapid heart rates over a 4–6 week period results in
cardiac remodeling and dysfunction, providing a model system of
high impact cardiac diseases including congestive heart failure [1]
and atrial fibrillation [2]. In addition, even at normal heart rates, it
has been shown that long-term right ventricular pacing in humans
can have deleterious effects on cardiac function, an observation
which has led to altered clinical guidelines for pacemaker
programming [3].
Although pacemakers were originally and primarily designed as
a treatment for slow heart rate (bradyarrhythmias), recent
developments have begun to highlight an array of more complex
and subtle effects of ectopic pacing on cardiac electrical function.
One seemingly simple example of pacemaker induced remodeling
is the observation that after a period of ectopic pacing, a persistent
alteration in T-wave axis (observed on the body surface ECG)
occurs, which can linger for weeks or months [4]. Although
originally viewed as a clinical curiosity, increasing research
indicates that this phenomenon known as cardiac memory
provides insight into the cellular and molecular changes provoked
by pacing [5]. A tentative model of pacemaker-induced changes
includes local angiotensin signaling, leading to ion channel
remodeling and resulting in heterogeneous prolongation of action
potentials. However, a complete description of ion channel
remodeling in cardiac memory is lacking and the underlying
molecular mechanisms remain incompletely understood [6].
PLOS ONE | www.plosone.org 1 October 2013 | Volume 8 | Issue 10 | e76291
One challenging aspect of studying pacemaker-induced phe-
nomenon is the choice of model system. Traditionally, larger
animal models, primarily canine, have been used to allow easier
implantation of the pacemaker. On the other hand, the mouse,
with its long history as a versatile and affordable genetic and
molecular model, offers a much wider range of tools to investigate
electrical remodeling in models of heart failure on the gene/
protein levels [7]. The first general feasibility study of pacemaker
implantation in the mouse was illustrated in a study by Bilchick
et al. in which they demonstrated that epicardial right ventricular
(RV) pacing in the mouse resulted in mechanical dyssynchrony
and differential gene expression in the lateral versus the septal
walls of the LV [8]. While Bilchick et al. were able to document
early signs of pacemaker-induced remodeling in the mouse, their
pacemaker only permitted reliable chronic pacing for a maximum
of 1 week at a rate of 720 BPM. The current study was undertaken
to design a pacemaker capable of pacing the mouse heart for 3–4
weeks in order to permit further exploration of pacemaker-
induced remodeling in the mouse. Here, we describe the
development of a fully implantable mouse pacemaker from a
traditional battery-powered design to a novel, low-cost, wireless-
powered pacemaker platform capable of pacing up to 30 days.
Methods
Fabrication of Battery-powered Pacemaker
We designed our printed circuit board (PCB) layout and
pacemaker circuit using free ExpressPCB CAD software (ex-
presspcb.com). Our PCB (Figure 1a) is a two-layer board with a
bottom copper layer (gray) for grounding and top copper web
(blue) for component attachment. Individual circular PCBs were
extracted from a card of 12 chips. All surface mount components
were manually soldered to each chip and can be ordered through
Digi-Key Corp. (Thief River Falls, MN) or Mouser Electronics
Inc. (Mansfield, TX). Prior to attachment, the PIC microcontroller
is reprogrammed with our source code using the PICkit 2
Development Programmer (Microchip Technology Inc., Chan-
dler, AZ), and 8-SOIC to 8-DIP adapter, and Microchip’s
MPLAB software. Source code for the microcontroller can be
found the Online Appendix.
Implant Procedure for Battery- and Wireless-powered
Pacemakers
All animal studies were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
following protocol was approved by the Institutional Animal
Studies Care and Use Committee of Washington University in St.
Louis (Protocol Number: 2010005 and 2013001). Adult mice
(n = 14) were anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg) administered intraperitoneally and then
restrained in a supine position on a heated magnetic stainless
steel surgical board under a low power binocular dissecting
microscope. In our original attempts to surgically implant a
battery-powered pacemaker, we used an external jugular ap-
proach. For this procedure, mice were prepared for surgery with
aseptic and anesthetic techniques. The mice were intubated with a
20-gauge 10 smooth needle through the oral cavity as verified by
direct visualization of the intubation device through the exposed
trachea. Mice were then ventilated at a tidal volume of 200–500 ml
and a rate of 140 strokes/minute. After mice reached an anesthetic
level for surgery, the neck skin was cut to expose the jugular vein.
The vein was isolated and secured with suture. A sterile battery-
powered pacemaker was then inserted into a subcutaneous pocket
formed by blunt dissection along the animal’s flank and back. The
pacing electrode was then fed through a sterile trocar under the
skin and into the site of the jugular isolation. A small incision was
made in the jugular vessel and the pacemaker lead was inserted
through the vessel and into the right ventricle of the heart. After
confirmation of pacing capture and good positioning of the extra
wire length, the pacemaker lead was secured into the jugular by
tying down the suture and placing a small drop of sterile tissue glue
on the vessel at the site of lead entrance. Both the neck and back
skin incisions were closed and mice were allowed to recover on a
warmer until being returned to their cage.
For the wireless-powered pacemaker, aseptic and anesthetic
techniques were followed as previously described in adult mice
(n = 10). Once a surgical plane of anesthesia was achieved in the
mouse, a small incision was made in the mid-thorax region
followed by blunt dissection to expose the larynx and trachea. A
short midline skin incision was made with reflection of the skin
directly above the base of the sternum. A subcutaneous skin pocket
was made below the sternum and right above the abdomen by
blunt dissection for placement of the flat pacemaker device. The
pacemaker was then positioned under the skin in this pocket to
meet the exact length required for the electrodes to enter the chest
at the 4th intercostal space. The chest was then opened by a lateral
cut along the left side of the sternum between the ribs. The chest
wall was retracted to better expose the apex of the left ventricle.
The sterile pacemaker electrode was then sewn with 8–0 suture to
the apical myocardial wall through either the anodal or cathodal
eyelet. It was also ensured that both electrodes were touching the
surface of the ventricular wall. The chest wall was then closed
around the electrode with a purse string. The surgical incision was
closed in two layers with an interrupted suture pattern. Mice were
then allowed to recover with oxygen on a heating pad until
extubation. Mice were monitored closely for 3 days following
surgery.
Following implantation and recovery, mice were monitored
daily. In cases of erosion of the device through the skin, mice were
euthanized at the time the erosion was identified. In all other cases
of death, no symptoms were evident prior to death. At the time of
sacrifice, mice were anesthetized with Avertin (0.5 mg/g) followed
by removal of the heart for inspection and identification of
complications.
Statistical Analysis
All statistical analysis was performed in Prism (GraphPad
Software, Inc., La Jolla, CA). An F-test was performed on the slope
of the regression line of the mean pacing pulse width thresholds to
determine significance compared to a slope of 0.
Results
Battery-powered Pacemaker
We began by creating a battery-powered design similar to
Bilchick et al. in order to better understand design criteria for an
implantable mouse pacemaker (Figure 1). Our battery-powered
device is based on the PIC12F675 microcontroller (Microchip
Technology Inc., Chandler, AZ). We chose the PIC12F675 for its
small size, low-cost and internal memory that enables 14 different
programmable stages. Using this microcontroller, we produced a
pacing circuit (Figure 1a) powered by a 3 V lithium coin-cell
battery (CR1220, 38 mAh). Additionally, we employed an
external 32 kHz crystal oscillator for low-power timing of
stimulation rates and pulse widths. Our design features 14 unique
combinations of pulse width (1 ms, 1.5 ms, 2.0 ms, or 2.5 ms) and
pacing rate (600 PPM, 700 PPM, 800 PPM, or 1000 PPM) on a
Wirelessly-Powered Mouse Pacemaker
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circular buffer, a low-power hibernation mode, and a magnetic
reed switch for external control once implanted. All circuit
elements were attached to a custom-designed, two-layer PCB
(Figure 1b). One key component of the pacemaker from Bilchick
and colleagues was an epicardial pacing electrode with a fixation
screw produced by Boston Scientific (St. Paul, MN; formerly
Guidant Corporation). Since this lead was not available to us, we
substituted a 1 Fr bipolar murine pacing catheter produced by
NuMed Inc. (Hopkinton, NY) on our device (Figure 1c). Similar
to human pacemaker implantation procedure, this pacing catheter
was guided into the right ventricle via the right jugular vein of the
mouse and used for endocardial pacing. To protect the device
against degradation from biological fluids, each device is
embedded in EPO-TEK 730 general-purpose epoxy (Epoxy
Technology, Inc., Billerica, MA). Fully assembled devices measure
17.2060.23 mm (diameter)68.8860.63 mm (thickness) with a
mass of 3.0760.10 g.
Similar to human pacemakers, this battery-powered mouse
pacemaker operates as a constant voltage pulse generator.
Figure 2a displays current and voltage traces recorded from
the pacing catheter in a saline bath. Additionally, we performed a
Frequency Response Analysis (FRA) on the pacing catheter to
measure electrode impedance as a function of waveform frequency
content (Figure 2b). Lead impedance of the pacing catheter
varies from 2.98–90.74 kV on the distal electrode and 1.78–62.99
kV on the proximal electrode. Based on bench-top testing and
battery rating (38 mAh), we estimated that this device should pace
reliably for approximately 30 days.
Battery-powered devices were implanted in mice (n = 14) as
specified in the Methods section. Following initial implantation,
device functionality was tested via an electrocardiogram (ECG)
and an echocardiogram to verify electrical and mechanical cardiac
capture. Mice were monitored daily for survival and device
functionality via an ECG. All ECG measurements were performed
under inhaled isofluorane anesthesia (1–2%). Eight of 14 (57.1%)
mice died within 1–2 days of implantation due to various causes
(e.g. RV perforation, surgical trauma, stroke, device removal by
animal). Of the survivors, 2 of 6 (33.3%) survived 4 days, 1 of 6
(16.7%) survived 6 days, 1 of 6 (16.7%) survived 8 days, and 2 of 6
(33.3%) survived 11 days. With respect to device functionality,
pacing was achieved in 9 of 14 (64.3%) mice. Chronic pacing was
achieved in two of the 4 (50%) mice that survived .4 days for a
maximum of 5 days and 6 days. Figure 2c depicts Lead II ECGs
recorded during sinus rhythm and chronic RV pacing over a 5-
day period.
Wireless-powered Pacemaker
Due to the high post-implant mortality with the battery-
powered pacemaker, we attempted to refine our pacemaker
design. We hypothesized that implant intolerance was primarily
due to device size as well as mechanical complications resulting
from placement of the endocardial lead. One of the larger
components of the battery-powered design, by mass and volume, is
the battery. Presently, lithium ion batteries with smaller size and
sufficient charge capacity do not exist. As a result, we began
exploring wireless energy transfer as a means for device power
without the use of a battery. Inductive energy transfer has been
Figure 1. Layout of the battery-powered mouse pacemaker. (a) Circuit design. (b) Printed circuit board. (c) Battery-powered pacemaker
coated in biocompatible epoxy with endocardial pacing catheter attached. Inset image features the tip of the bipolar pacing catheter.
doi:10.1371/journal.pone.0076291.g001
Wirelessly-Powered Mouse Pacemaker
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used extensively for both power and data communication in
implantable devices for various biological applications [9–11].
Similar to these designs, we developed a wireless-powered
pacemaker consisting of three major components: a function
generator, an external transmitter, and a passive receiver. Power
transmission is achieved through a modified Class-E power
oscillator (Figure 3a, top) (EZ, MM, JL; Unpublished data).
An external function generator (26T, AD Instruments, Inc.,
Colorado Springs, CO) is used to generate a pulsed input (Fig. 3b)
that modulates pacing rate and pulse width of an external
transmitter circuit. This oscillator circuit operates at a carrier
frequency of 5 MHz and approximately 390 V peak-to-peak
(Figure 3c). Near-field magnetic coupling occurs between an
external transmitter coil and a tuned, implanted receiver circuit
that drives constant-voltage, monophasic pulses through the
implant (Fig. 3a, bottom). As a result of the large voltage from
the transmitter, we were able to design a passive receiver without
additional amplifiers. Figure 3d displays the output of the
receiver over a 5-kV resistor with a coil-to-coil distance of 45 mm.
Since the minimal cage size required for housing a single mouse is
4 cm64 cm, this range is adequate to permit powering a device in
a freely moving mouse. However, additional optimization of the
transmitter/receiver system can be made in the future to increase
this range. To reduce the influence of mouse position within the
transmitter coil, a Zener diode was connected to the output of the
device to cap the stimulation voltage at 3.9 V. Figure 3e
demonstrates the output waveform after diode capping. Figure 3f
demonstrates that device output remains relatively constant over a
range of 0–5 cm from the transmitter; this output was sufficient at
5 cm for reliable cardiac pacing. All electrical components for the
transmitter and receiver are listed in Table 1.
The receiver coil and pacing circuit are assembled on a flexible
polyimide PCB (Red Rock Laboratories, LLC, St. Louis, MO) to
reduce device thickness and attached to a platinum bipolar pacing
electrode. Figure 4a demonstrates the lead attachment process to
the polyimide PCB. Briefly, two pieces of PFA-insulated platinum-
iridium wire (0.0050 bare uncoated, 0.0080 coated, A-M Systems,
Sequim, WA) are soldered to the PCB. The wires are braided
together and coiled at the ends with a 0.5cc syringe. Several
iterations of the pacing electrode were attempted (straight wire,
braided wire, and braided wired with eyelets) before settling on the
pacing electrode in the final design (Figure 4c). We found that the
braided wire with eyelets sutured to the apex minimized the
potential for serious complications due to an internal puncture
wound. Once the pacing electrode is attached, the implant is
embedded in Silastic medical adhesive (Dow Corning, Midland,
MI) (Figure 4b). Silastic was selected for device potting to reduce
the mechanical mismatch between the lead and the circuit board,
minimizing potential shearing of the lead. Device encapsulation is
performed by first depositing a bead of Silastic on parafilm
(Figure 4b1). Next, the device is pressed into the bead of Silastic
(Figure 4b2) and an additional layer is added to the top
Figure 2. Bench top and in vivo testing of battery powered pacemaker. (a) Current (blue) and voltage (gray) traces from the pacing catheter.
(b) Frequency Response Analysis of distal and proximal pacing catheter electrodes (c) Lead II ECG recording in a mouse heart during sinus rhythm and
right ventricular pacing by the battery-powered pacemaker over 5 days.
doi:10.1371/journal.pone.0076291.g002
Wirelessly-Powered Mouse Pacemaker
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(Figure 4b3). A final layer of areaseal film is pressed on the top of
the device to join the upper and lower layers of Silastic
(Figure 4b4). The use of gas-permeable areaseal film was found
to be essential to allow curing of Silastic. The device is cured at
room temperature for 3 days and then trimmed of excess.
Figure 4c shows the final assembled product. Each device
measures approximately 13.6560.25 mm (diame-
ter)63.2760.50 mm (thickness) and weights 0.5660.07 g, a 82%
reduction by mass and 77% reduction by volume compared to the
battery-powered design. In order to reduce surgical complexity,
our wireless design was developed as an epicardial pacemaker.
Briefly, the receiver is placed subcutaneously in the mouse
abdominal region and the pacing lead is sutured to the epicardium
of left ventricular (LV) apex. A more complete description of the
implant technique is provided in the Methods section.
Wireless-powered devices were implanted in mice (n = 10) as
specified in theMethods section. Device functionality was verified in
all ten (100%) mice at implant via ECG. Echocardiographic
measurements were not acquired due to interference concerns
between the transmitter and the echo machine. Following a five-
day recovery period, ventricular pacing was conducted under
isofluorane anesthesia (1–2%) at 5 day intervals for 30 days. Due
to the fact that a cage system incorporating the transmitter coils
remains under development, the wireless device was not contin-
uously powered (in contrast to the battery device described above)
but was only powered with a transmitter coil during testing at 5
day intervals to verify stability of device function. At each follow-
Figure 3. Layout of the wireless-powered pacemaker. (a) Circuit layout of transmitter (top) and receiver (bottom). (b) Pulsed input into
transmitter from pulse generator. (c) Output from transmitter. (d) Uncapped output from receiver. (e) Capped output from receiver. (f) Receiver
output decreases minimally up to 5 cm from the transmitter coil. See text for further details.
doi:10.1371/journal.pone.0076291.g003
Wirelessly-Powered Mouse Pacemaker
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up, pacing pulse-width threshold at 600–630 BPM was tested. On
post-operative day 30, ability to pace above intrinsic physiologic
rates (.750 BPM) was tested.
Nine of 10 (90%) mice survived device implantation with the
wireless-powered device. Of the survivors, 6 of 9 (66.7%) mice
survived 20 days (one mouse died on postoperative day 5, one on
postoperative day 14, and one was euthanized on postoperative
day 10 due to erosion of the device through the skin). Necropsies
were performed but no cause of death was identified. Twenty days
post implant, 5 of 6 devices functioned properly. One device
exhibited unreliable capture at 600 BPM; therefore pacing with
reliable cardiac capture was successfully achieved in 4 of 6 (66.7%)
mice for 20 days. In addition, three devices continued to exhibit
stable function for up to 30 days. Figure 5a shows a
representative example of normal sinus rhythm and pacing at
600 BPM. Pacing at .750 BPM was achieved in all three (100%)
mice with functional devices on post-operative day 30. Figure 5b
shows the measured pulse width thresholds over the 30-day period
for all mice with stable device function. An ordinary least squares
regression on the mean pulse width threshold with 95%
confidence interval bounds is superimposed in red (slo-
pe =20.161.1 ms/day, p = 0.93 compared to a slope of 0).
Discussion
This study describes the design and implementation of a
miniature, implantable wireless pacemaker for mice with off-the-
shelf electronic components. This wireless design described herein
has considerable advantages over a traditional battery-powered
pacemaker. A list of contrasting device features is provided in
Table 2.
First and foremost, our wireless-powered pacemaker is 82%
smaller by mass and 77% smaller by volume compared to our
battery-powered design. Compared to the battery-powered device
described by Bilchick et al. [8], our wireless device is 66.7%
Table 1. Parts list for wireless transmitter and receiver
circuits.
Transmitter Circuit






L Trans 9.1 mH
L Choke 150 mH
C1 138 pF
Receiver Circuit






Figure 4. Assembly process of wireless powered pacemaker. (a) Platinum wire is attached to the circuit board, wound together, and coiled
with a 0.5 cc syringe. (b) A bead of Silastic is placed on a piece of parafilm(1). The device is placed on the bead(2), coated with an additional layer of
Silastic(3), and topped with a piece of gas permeable film(4). (c) Final product. (d) Artistic rendering of external transmitter interacting with
abdominally implanted receiver in mouse.
doi:10.1371/journal.pone.0076291.g004
Wirelessly-Powered Mouse Pacemaker
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smaller by mass. Reduction in the amount of implantable material
is likely a key factor to reducing the morbidity and mortality of the
pacemaker implant procedure. Despite our best efforts, a
significant incidence of animal mortality was observed immedi-
ately following implantation of our battery-powered device: 57.1%
with the battery-powered pacemaker (similar to a 40% mortality
rate reported by Bilchik et al.) compared to 10% with the wireless-
powered pacemaker. High implant mortality may be largely
attributed to the large size of the battery-powered devices in our
design and that of Bilchick and colleagues.
Second, we demonstrate successful pacing for 30 days with our
wireless device, a significant improvement compared to the one
week of reliable pacing reported in previous studies [8]. This
increase in device life can be attributed to the use of wireless power
in our design. Our wireless device is not limited by finite battery
life or rapid battery drain due shorting of the device once
implanted. In bench-top testing in a saline bath, pacemaker
function remained stable for 3 months.
External control of our wireless device increases device
flexibility and functionality. Pulse width and pacing rate can be
adjusted on demand and are not limited to values preprogrammed
onto a microchip. Additionally, programmed stimulation protocols
(e.g., S1S1, S1S2, S1S3, etc.) can be created on an external
function generator to perform sophisticated electrophysiological
testing in vivo.
Figure 5. In vivo testing of wireless pacemaker. (a) Lead II ECG during normal sinus rhythm (top) and during LV apical pacing (bottom). (b)
Pacing pulse width threshold of wireless device over 30 days for all mice with stable capture. Solid red line shows linear regression on mean pulse
width thresholds. Dashed black lines show 95% confidence interval bounds for the regression.
doi:10.1371/journal.pone.0076291.g005
Table 2. Comparison of battery-powered and wireless-
powered pacemakers.
DEVICE Battery Wireless
MASS 3.07 g 0.56 g
SIZE 8.9617.2 mm 3.3613.7 mm
LIFE 30 days ,3 month
CONTROL microchip external
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Finally, cost and ease of implant were carefully considered
during the development of a fully implantable pacemaker for mice.
In our original battery-powered design, we used a 1 Fr. murine
pacing catheter developed by NuMed, Inc. as our pacing
electrode. While the placement of this electrode in the RV
endocardium more closely resembles pacing in canines, consistent
placement of the pacing catheter in the RV required a skilled
mouse surgeon and occasional use of echocardiography and, even
so, increased peri-operative mortality due to RV perforation.
Additionally, the NuMed catheter added significant cost to the
battery-powered design ($250 of the $275 total cost). By decreasing
device size and pursuing an epicardial pacing strategy, we were
able to greatly reduce the complexity of the implant procedure.
Moreover, by replacing the NuMed catheter with standard
platinum-iridium wire, a complete build for a wireless-powered
pacemaker can be assembled for approximately $30.
Conclusions
Here we demonstrate a successful implementation of a fully
implantable mouse pacemaker based on wireless power transfer
and control capable of 30 days of in vivo pacing. For the purpose
of device testing, all experiments in this study were performed on
anesthetized animals with a hand-held transmitter. In order to
chronically pace freely roaming mice, we integrated a transmitter
coil into the mouse housing. This system is designed to generate
voltage fields in excess of the 3.9 V cap on the receiver throughout
the cage to eliminate communication issues between the trans-
mitter and receiver. This will ensure that mice will always be
paced independent of the location they occupy in the cage.
The development of a practical pacemaker for long-term studies
in the mouse will permit a range of future studies. First, the
development of the mouse as a model of cardiac memory will
allow the well-developed molecular and genetic tools available in
this animal to be brought to bear on the mechanism(s) underlying
pacemaker-induced cardiac electrical remodeling. Second, long-
term pacing at supra-physiological rates can result in heart failure
and atrial fibrillation, both common pathologies amenable to
further genetic studies in the mouse. While the current design is
sufficient for physiologic testing, future development will focus on
potential improvement to the pacing electrode and the creation of
an electrical sensing circuit. During some experiments, subtle
chest-wall captured was observed during pacing. Further modifi-
cations of the lead design with novel printing strategies on flexible
substrates and improvements to the surgical method should
mitigate this issue. Additionally, our receiver circuit is a dedicated
pacing circuit without sensing capabilities. Stimulation and sensing
with radiofrequency induction has been demonstrated previously
for neural applications [12]. Future research will focus on adopting
this technology for our pacemaker. We anticipate that further
development of this technology will open the door to a range of
cardiac studies in the mouse.
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